Skip to main content
OpenTrials
Completed

NCT Number: NCT07668128

Tactile Feedback Pelvic Floor Training to Prevent Stress Urinary Incontinence in the 3rd Trimester of Pregnancy

Pregnancy involves significant physiological changes, such as hormone fluctuations, weight gain, and fetal growth, which can affect multiple organ systems. These changes often lead to symptoms like stress urinary incontinence (SUI) and may worsen existing conditions. SUI affects about one-third of pregnant women and can decrease quality of life.

Pelvic floor muscle exercise (PFME) is a recommended treatment to manage urinary incontinence during pregnancy and postpartum. This study aims to compare the effectiveness of three interventions: routine health education, traditional PFME, and tactile feedback PFME, on reducing SUI symptoms, shortening the second stage of labor, and improving quality of life.

Participants will be enrolled in their third trimester and randomly assigned to one of the three groups, with each intervention lasting 8 weeks. Outcome measures include urinary symptoms (via bladder diary, UDI-6, and IIQ-7), quality of life (via KHQ and WHOQOL-BREF), and labor outcomes (duration of the second stage).

Completed

Looking for future studies?

Notify Me

Key information

About this study

This study compares the effectiveness of three interventions-routine health education, traditional pelvic floor muscle exercise (PFME), and tactile feedback PFME-in improving urinary incontinence in pregnant women. Participants will receive one of these interventions over 8 weeks during the third trimester. The primary outcome measures include changes in urinary incontinence symptoms, quality of life,and the duration of the second stage of labor. Participants will be evaluated at baseline and 8 weeks post-intervention. This study also aims to determine whether tactile feedback PFME is more effective than traditional PFME or routine health education in reducing urinary incontinence symptoms and improving labor outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women diagnosed with urinary incontinence by obstetricians or gynecologists during prenatal care.
  • Women aged 20 years or older.
  • Pregnant at 29 weeks of gestation.
  • Singleton pregnancy with cephalic presentation.
  • Anticipated vaginal delivery.
  • Able to communicate and complete questionnaires without difficulty.
  • Willing to participate and provide informed consent.

Exclusion criteria

  • Diagnosed with high-risk pregnancy or at risk of preterm labor.
  • Visual impairment or physical disability that limits participation.
  • Currently taking medication for urinary incontinence during pregnancy.

Treatment and study plan

Pelvic floor muscle training

Behavioral

"Four in-person traditional pelvic floor muscle training sessions are scheduled over an eight-week period. The training involves interactive, hands-on teaching that incorporates body positioning, guided breathing, and the 'closing and opening gate' theory. This includes imagery techniques such as buttock squeezing and simulating the action of stopping urine flow to facilitate pelvic floor muscle contractions.

Basic Health Education Group

Behavioral

One-way, one-time health education leaflets are provided for written teaching, with only explanations but no physical teaching. The content of the health education leaflets includes urinary incontinence during pregnancy, its causes, daily diet, weight control, and Kegel exercise execution methods and movements.

Tactile pelvic floor muscle training group

Behavioral

There are four physical tactile pelvic floor muscle training courses arranged in eight weeks. The training process adopts two-way interactive practical teaching, using movement positioning and deep breathing to induce adjustment of the upper and lower strength of the pelvic floor, and using finger tactile feedback to feel the muscles lifting and contracting up and down during training.

Primary outcomes

  1. Urinary Symptoms (Bladder Diary)

    Time frame: Baseline, 4 weeks, and 8 weeks post-intervention

    Mean number of normal voiding episodes per day, urinary incontinence episodes per day, urinary urgency episodes per day, and mean daily fluid intake recorded using a 3-day bladder diary.

  2. Urinary Symptom Distress (UDI-6)

    Time frame: Baseline, 4 weeks, and 8 weeks post-intervention

    Total score measured using the Urinary Distress Inventory-6 (UDI-6). Scores range from 0 to 100, with higher scores indicating greater urinary symptom distress.

  3. Incontinence Impact on Daily Life (IIQ-7)

    Time frame: Baseline, 4 weeks, and 8 weeks post-intervention

    Total score measured using the Incontinence Impact Questionnaire-7 (IIQ-7). Scores range from 0 to 100, with higher scores indicating greater impact of urinary incontinence on daily activities.

  4. Urinary Incontinence-Related Quality of Life (KHQ)

    Time frame: Baseline, 4 weeks, and 8 weeks post-intervention

    Domain scores measured using the King's Health Questionnaire (KHQ), including General Health Perception, Role Limitation, Physical Limitation, Social Limitation, Personal Relationships, Emotions, Sleep/Energy, and Severity Measures. Scores range from 0 to 100, with higher scores indicating poorer quality of life.

  5. Global Quality of Life (WHOQOL-BREF Taiwan Version)

    Time frame: Baseline, 4 weeks, and 8 weeks post-intervention

    Total score measured using the WHOQOL-BREF Taiwan Version. Higher scores indicate better quality of life.

Secondary outcomes

  1. Duration of Second Stage of Labor

    Time frame: At delivery

    Duration of the second stage of labor obtained from medical records.

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Official study title

Tactile Feedback on Pelvic Floor Muscle Training in the 3rd Trimester of Pregnancy to Prevent of Stress Urinary Incontinence and Its Influence on Biological and Psychological Symptoms

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jun 25, 2026
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.